Joseph Keawe'aimoku Kaholokula
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hawaii | 53 | 2024 | 1929 | 3.650 |
Why?
|
| Health Promotion | 10 | 2023 | 653 | 2.770 |
Why?
|
| Health Status Disparities | 13 | 2023 | 642 | 2.740 |
Why?
|
| Dancing | 5 | 2017 | 22 | 2.190 |
Why?
|
| Community-Based Participatory Research | 8 | 2019 | 317 | 1.950 |
Why?
|
| Diabetes Mellitus, Type 2 | 11 | 2023 | 643 | 1.850 |
Why?
|
| Cardiovascular Diseases | 8 | 2023 | 664 | 1.820 |
Why?
|
| Obesity | 12 | 2023 | 1067 | 1.810 |
Why?
|
| Cultural Characteristics | 6 | 2017 | 125 | 1.810 |
Why?
|
| Diabetes Mellitus | 7 | 2019 | 485 | 1.770 |
Why?
|
| Stress, Psychological | 7 | 2018 | 583 | 1.620 |
Why?
|
| Hypertension | 7 | 2023 | 796 | 1.560 |
Why?
|
| Prejudice | 3 | 2022 | 110 | 1.470 |
Why?
|
| Psychometrics | 2 | 2024 | 318 | 1.450 |
Why?
|
| Humans | 78 | 2024 | 37093 | 1.430 |
Why?
|
| Life Style | 6 | 2023 | 308 | 1.360 |
Why?
|
| Female | 51 | 2024 | 20969 | 1.260 |
Why?
|
| Adult | 40 | 2024 | 11712 | 1.240 |
Why?
|
| Middle Aged | 34 | 2024 | 10129 | 1.190 |
Why?
|
| Male | 46 | 2024 | 20025 | 1.170 |
Why?
|
| Social Support | 10 | 2020 | 394 | 1.080 |
Why?
|
| Depression | 8 | 2018 | 712 | 1.020 |
Why?
|
| Blood Pressure | 7 | 2023 | 646 | 1.000 |
Why?
|
| Statistics as Topic | 2 | 2023 | 117 | 0.930 |
Why?
|
| Disaster Planning | 1 | 2023 | 52 | 0.860 |
Why?
|
| Patient Education as Topic | 3 | 2020 | 215 | 0.850 |
Why?
|
| Aged | 21 | 2024 | 6741 | 0.840 |
Why?
|
| Resilience, Psychological | 2 | 2020 | 66 | 0.840 |
Why?
|
| Adaptation, Psychological | 3 | 2017 | 385 | 0.830 |
Why?
|
| Acculturation | 4 | 2019 | 188 | 0.830 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 128 | 0.820 |
Why?
|
| Chronic Disease | 3 | 2017 | 484 | 0.820 |
Why?
|
| Self Care | 4 | 2016 | 159 | 0.790 |
Why?
|
| Program Development | 3 | 2020 | 233 | 0.790 |
Why?
|
| Weight Loss | 5 | 2023 | 131 | 0.760 |
Why?
|
| Indians, North American | 4 | 2022 | 159 | 0.740 |
Why?
|
| Cross-Sectional Studies | 15 | 2024 | 2721 | 0.720 |
Why?
|
| Attitude of Health Personnel | 1 | 2022 | 198 | 0.700 |
Why?
|
| Health Services Needs and Demand | 2 | 2013 | 146 | 0.700 |
Why?
|
| Overweight | 4 | 2023 | 247 | 0.690 |
Why?
|
| Coronary Disease | 1 | 2020 | 124 | 0.690 |
Why?
|
| Tobacco Use Disorder | 2 | 2021 | 237 | 0.670 |
Why?
|
| Social Identification | 3 | 2016 | 58 | 0.660 |
Why?
|
| Focus Groups | 6 | 2024 | 348 | 0.660 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 68 | 0.650 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 76 | 0.640 |
Why?
|
| Family | 2 | 2011 | 173 | 0.630 |
Why?
|
| Exercise | 6 | 2021 | 613 | 0.620 |
Why?
|
| Young Adult | 12 | 2024 | 4268 | 0.610 |
Why?
|
| Evidence-Based Medicine | 2 | 2015 | 97 | 0.600 |
Why?
|
| Pilot Projects | 5 | 2022 | 661 | 0.600 |
Why?
|
| Women's Health | 2 | 2018 | 145 | 0.590 |
Why?
|
| Workplace | 1 | 2018 | 87 | 0.590 |
Why?
|
| Self-Help Groups | 1 | 2016 | 8 | 0.570 |
Why?
|
| Heart Rate | 1 | 2018 | 253 | 0.560 |
Why?
|
| Social Perception | 1 | 2017 | 62 | 0.560 |
Why?
|
| Community Health Services | 3 | 2021 | 185 | 0.560 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2016 | 864 | 0.540 |
Why?
|
| Diffusion of Innovation | 1 | 2016 | 35 | 0.540 |
Why?
|
| Adolescent | 13 | 2024 | 5363 | 0.530 |
Why?
|
| Smoking | 6 | 2016 | 940 | 0.500 |
Why?
|
| Health Status | 2 | 2014 | 380 | 0.480 |
Why?
|
| Attitude to Health | 2 | 2008 | 325 | 0.470 |
Why?
|
| Risk Factors | 10 | 2023 | 3562 | 0.470 |
Why?
|
| Aged, 80 and over | 8 | 2024 | 2379 | 0.460 |
Why?
|
| Cultural Competency | 4 | 2023 | 131 | 0.460 |
Why?
|
| Quality of Life | 3 | 2014 | 481 | 0.460 |
Why?
|
| Mental Disorders | 1 | 2017 | 309 | 0.440 |
Why?
|
| Program Evaluation | 4 | 2017 | 339 | 0.440 |
Why?
|
| Socioeconomic Factors | 8 | 2019 | 1067 | 0.440 |
Why?
|
| Prevalence | 11 | 2023 | 1455 | 0.430 |
Why?
|
| Breast Neoplasms | 1 | 2023 | 1502 | 0.410 |
Why?
|
| Culture | 4 | 2018 | 173 | 0.390 |
Why?
|
| Secondary Prevention | 1 | 2011 | 38 | 0.390 |
Why?
|
| Residence Characteristics | 3 | 2020 | 322 | 0.390 |
Why?
|
| Biomedical Research | 1 | 2015 | 400 | 0.380 |
Why?
|
| Dementia | 2 | 2022 | 131 | 0.360 |
Why?
|
| Blood Glucose | 5 | 2016 | 353 | 0.350 |
Why?
|
| Minority Groups | 4 | 2023 | 596 | 0.350 |
Why?
|
| Stress, Physiological | 1 | 2011 | 150 | 0.350 |
Why?
|
| Heart Failure | 2 | 2014 | 235 | 0.350 |
Why?
|
| Regression Analysis | 5 | 2016 | 455 | 0.340 |
Why?
|
| Reproducibility of Results | 2 | 2024 | 935 | 0.330 |
Why?
|
| Health Services Research | 1 | 2008 | 148 | 0.300 |
Why?
|
| Cooperative Behavior | 3 | 2016 | 219 | 0.300 |
Why?
|
| Diet | 5 | 2023 | 801 | 0.300 |
Why?
|
| Models, Theoretical | 2 | 2020 | 217 | 0.280 |
Why?
|
| Interviews as Topic | 4 | 2018 | 381 | 0.280 |
Why?
|
| Qualitative Research | 3 | 2017 | 446 | 0.270 |
Why?
|
| Caregivers | 1 | 2008 | 182 | 0.260 |
Why?
|
| Factor Analysis, Statistical | 1 | 2024 | 146 | 0.230 |
Why?
|
| Community-Institutional Relations | 2 | 2016 | 187 | 0.230 |
Why?
|
| New Zealand | 3 | 2019 | 21 | 0.230 |
Why?
|
| Health Behavior | 4 | 2018 | 537 | 0.230 |
Why?
|
| Smoking Cessation | 2 | 2016 | 517 | 0.220 |
Why?
|
| Guam | 1 | 2023 | 79 | 0.220 |
Why?
|
| Family Relations | 2 | 2017 | 46 | 0.220 |
Why?
|
| Rural Health | 2 | 2017 | 53 | 0.220 |
Why?
|
| Comparative Effectiveness Research | 2 | 2019 | 15 | 0.210 |
Why?
|
| Students | 2 | 2018 | 519 | 0.200 |
Why?
|
| Food Supply | 1 | 2023 | 112 | 0.200 |
Why?
|
| Sex Factors | 2 | 2020 | 898 | 0.200 |
Why?
|
| Marketing | 1 | 2021 | 40 | 0.200 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 149 | 0.190 |
Why?
|
| Healthcare Disparities | 2 | 2020 | 494 | 0.190 |
Why?
|
| Mental Health | 2 | 2014 | 303 | 0.190 |
Why?
|
| Medicare | 1 | 2022 | 195 | 0.190 |
Why?
|
| Health Education | 2 | 2016 | 338 | 0.180 |
Why?
|
| Public Health | 2 | 2015 | 372 | 0.180 |
Why?
|
| Logistic Models | 4 | 2013 | 923 | 0.180 |
Why?
|
| Body Weight | 2 | 2013 | 434 | 0.180 |
Why?
|
| United States | 8 | 2024 | 4223 | 0.180 |
Why?
|
| Self Efficacy | 1 | 2021 | 184 | 0.180 |
Why?
|
| Hospitalization | 2 | 2020 | 388 | 0.170 |
Why?
|
| Peer Group | 1 | 2020 | 156 | 0.170 |
Why?
|
| Asthma | 1 | 2023 | 380 | 0.170 |
Why?
|
| Perception | 2 | 2011 | 195 | 0.170 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 885 | 0.160 |
Why?
|
| Research | 1 | 2020 | 163 | 0.160 |
Why?
|
| Health Surveys | 1 | 2020 | 373 | 0.160 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2021 | 404 | 0.160 |
Why?
|
| Preventive Health Services | 1 | 2018 | 64 | 0.150 |
Why?
|
| Religion | 1 | 2018 | 87 | 0.150 |
Why?
|
| Poverty Areas | 1 | 2017 | 41 | 0.150 |
Why?
|
| Prospective Studies | 1 | 2021 | 1378 | 0.150 |
Why?
|
| Clinical Protocols | 1 | 2017 | 36 | 0.150 |
Why?
|
| Workload | 1 | 2017 | 22 | 0.150 |
Why?
|
| Safety | 1 | 2017 | 48 | 0.140 |
Why?
|
| Mental Health Services | 1 | 2018 | 118 | 0.140 |
Why?
|
| Occupational Health Services | 1 | 2016 | 8 | 0.140 |
Why?
|
| Lipoproteins, HDL | 1 | 2016 | 46 | 0.140 |
Why?
|
| Lipoproteins, LDL | 1 | 2016 | 62 | 0.140 |
Why?
|
| Triglycerides | 1 | 2016 | 138 | 0.140 |
Why?
|
| Risk Reduction Behavior | 1 | 2016 | 127 | 0.130 |
Why?
|
| Organizations, Nonprofit | 1 | 2014 | 6 | 0.130 |
Why?
|
| Electric Capacitance | 1 | 2014 | 7 | 0.130 |
Why?
|
| Cholesterol | 1 | 2016 | 205 | 0.130 |
Why?
|
| Spiritual Therapies | 1 | 2014 | 9 | 0.130 |
Why?
|
| Capacity Building | 1 | 2016 | 87 | 0.130 |
Why?
|
| Mentors | 1 | 2016 | 127 | 0.120 |
Why?
|
| Patient Selection | 1 | 2015 | 164 | 0.120 |
Why?
|
| Stroke Volume | 1 | 2014 | 89 | 0.120 |
Why?
|
| Metabolic Equivalent | 1 | 2013 | 4 | 0.120 |
Why?
|
| Pacific Islands | 2 | 2016 | 119 | 0.120 |
Why?
|
| Glucose Intolerance | 2 | 2007 | 42 | 0.120 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2014 | 85 | 0.120 |
Why?
|
| Research Design | 1 | 2015 | 313 | 0.120 |
Why?
|
| Rural Population | 2 | 2024 | 294 | 0.120 |
Why?
|
| American Samoa | 1 | 2013 | 16 | 0.110 |
Why?
|
| Adolescent Behavior | 1 | 2016 | 253 | 0.110 |
Why?
|
| Analysis of Variance | 2 | 2006 | 550 | 0.110 |
Why?
|
| Micronesia | 1 | 2013 | 80 | 0.110 |
Why?
|
| Alzheimer Disease | 1 | 2020 | 905 | 0.110 |
Why?
|
| Schools, Medical | 1 | 2014 | 198 | 0.110 |
Why?
|
| Minority Health | 2 | 2012 | 88 | 0.110 |
Why?
|
| Energy Metabolism | 1 | 2013 | 168 | 0.110 |
Why?
|
| Dietary Fats | 1 | 2013 | 119 | 0.100 |
Why?
|
| Needs Assessment | 1 | 2013 | 170 | 0.100 |
Why?
|
| World Health Organization | 2 | 2010 | 31 | 0.100 |
Why?
|
| Behavior Therapy | 1 | 2013 | 167 | 0.100 |
Why?
|
| Age Distribution | 2 | 2010 | 225 | 0.100 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 583 | 0.100 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 358 | 0.090 |
Why?
|
| Comorbidity | 3 | 2003 | 623 | 0.090 |
Why?
|
| Hydrocortisone | 1 | 2011 | 78 | 0.090 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 974 | 0.090 |
Why?
|
| Academies and Institutes | 1 | 2008 | 37 | 0.080 |
Why?
|
| Nursing Methodology Research | 1 | 2008 | 14 | 0.080 |
Why?
|
| Polynesia | 1 | 2008 | 7 | 0.080 |
Why?
|
| Samoa | 1 | 2008 | 16 | 0.080 |
Why?
|
| Medicine, Traditional | 1 | 2008 | 23 | 0.080 |
Why?
|
| Spirituality | 1 | 2008 | 49 | 0.080 |
Why?
|
| Sex Distribution | 2 | 2006 | 215 | 0.080 |
Why?
|
| HIV Infections | 1 | 2021 | 2303 | 0.080 |
Why?
|
| Communication Barriers | 1 | 2008 | 56 | 0.080 |
Why?
|
| Body Mass Index | 2 | 2010 | 854 | 0.070 |
Why?
|
| Physician-Patient Relations | 1 | 2008 | 128 | 0.070 |
Why?
|
| Trust | 1 | 2008 | 133 | 0.070 |
Why?
|
| Diabetes, Gestational | 1 | 2006 | 47 | 0.070 |
Why?
|
| Pregnancy Outcome | 1 | 2006 | 87 | 0.070 |
Why?
|
| Mass Screening | 1 | 2010 | 462 | 0.070 |
Why?
|
| Chi-Square Distribution | 1 | 2006 | 225 | 0.070 |
Why?
|
| Delivery of Health Care | 1 | 2008 | 276 | 0.070 |
Why?
|
| Child | 2 | 2024 | 3131 | 0.060 |
Why?
|
| Diabetes Complications | 1 | 2006 | 90 | 0.060 |
Why?
|
| Neoplasms | 1 | 2015 | 1103 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2019 | 268 | 0.060 |
Why?
|
| Consciousness | 1 | 2023 | 5 | 0.060 |
Why?
|
| Health Services Accessibility | 1 | 2008 | 560 | 0.060 |
Why?
|
| California | 1 | 2023 | 476 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2021 | 111 | 0.050 |
Why?
|
| Health Services, Indigenous | 1 | 2020 | 24 | 0.040 |
Why?
|
| Health Personnel | 1 | 2022 | 228 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2020 | 291 | 0.040 |
Why?
|
| Advisory Committees | 1 | 2019 | 29 | 0.040 |
Why?
|
| Diet Surveys | 1 | 2019 | 101 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2019 | 208 | 0.040 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 145 | 0.040 |
Why?
|
| Aging | 1 | 2022 | 664 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2018 | 253 | 0.040 |
Why?
|
| Cross-Cultural Comparison | 1 | 2016 | 107 | 0.030 |
Why?
|
| Philippines | 1 | 2015 | 73 | 0.030 |
Why?
|
| Cotinine | 1 | 2015 | 43 | 0.030 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2015 | 25 | 0.030 |
Why?
|
| Risk | 1 | 2015 | 267 | 0.030 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2014 | 65 | 0.030 |
Why?
|
| Saliva | 1 | 2015 | 107 | 0.030 |
Why?
|
| Echocardiography | 1 | 2014 | 144 | 0.030 |
Why?
|
| Community Networks | 1 | 2015 | 108 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2015 | 260 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2013 | 103 | 0.030 |
Why?
|
| Universities | 1 | 2016 | 442 | 0.030 |
Why?
|
| Nicotine | 1 | 2015 | 257 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2014 | 225 | 0.030 |
Why?
|
| Dance Therapy | 1 | 2012 | 5 | 0.030 |
Why?
|
| Feeding Behavior | 1 | 2016 | 454 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 2014 | 519 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 400 | 0.020 |
Why?
|
| Hospitals, Teaching | 1 | 2008 | 27 | 0.020 |
Why?
|
| Social Marketing | 1 | 2008 | 25 | 0.020 |
Why?
|
| Hyperbilirubinemia, Neonatal | 1 | 2006 | 3 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2007 | 68 | 0.020 |
Why?
|
| Fetal Macrosomia | 1 | 2006 | 12 | 0.020 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2006 | 29 | 0.020 |
Why?
|
| Birth Weight | 1 | 2006 | 90 | 0.020 |
Why?
|
| Gestational Age | 1 | 2006 | 190 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2006 | 894 | 0.010 |
Why?
|
| Pregnancy | 1 | 2006 | 1549 | 0.010 |
Why?
|
| Linear Models | 1 | 2002 | 275 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2006 | 2026 | 0.010 |
Why?
|
| Psychological Tests | 1 | 2000 | 53 | 0.010 |
Why?
|
| Life Change Events | 1 | 2000 | 92 | 0.010 |
Why?
|
| Educational Status | 1 | 2000 | 313 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2000 | 534 | 0.010 |
Why?
|